Abstract
Objective
Test the hypothesis that exercise training would increase endothelin-mediated vasoconstriction in collateral-dependent arteries via enhanced contribution of ETA.
Methods
An ameroid constrictor was surgically placed around the proximal LCX artery to induce gradual occlusion in Yucatan miniature swine. Eight-weeks postoperatively, pigs were randomized into sedentary or exercise-training (treadmill; 5 days/wk; 14 wks) groups. Subsequently, arteries (~150 μm diameter) were isolated from collateral-dependent and nonoccluded myocardial regions and studied.
Results
Following exercise training, ET-1-mediated contraction was significantly enhanced in collateral-dependent arteries. Exercise training induced a disproportionate increase in the ETA contribution to the ET-1 contractile response in collateral-dependent arteries, with negligible contributions by ETB. In collateral-dependent arteries of sedentary pigs, inhibition of ETA or ETB did not significantly alter ET-1 contractile responses in collateral-dependent arteries, suggesting compensation by the functionally active receptor. These adaptations occurred without significant changes in ETA, ETB, or ECE mRNA levels but with significant exercise training-induced elevations in endothelin levels in both nonoccluded and collateral-dependent myocardial regions
Conclusions
Taken together, these data reveal differential adaptive responses in collateral-dependent arteries based upon physical activity level. ETA and ETB appear to compensate for one another to maintain contraction in sedentary pigs, whereas exercise-training favors enhanced contribution of ETA.
Keywords: coronary artery disease, near-resistance arteries, coronary artery occlusion, stenosis
Introduction
ET-1 is cleaved from its precursor, big endothelin, by ECE in vascular endothelial cells and binds to ETA and ETB to elicit its vasoactive effects. Functionally, ET-1 binds with its receptors in vascular smooth muscle and induces vasoconstriction. ETA is found mainly on vascular smooth muscle and is predominantly responsible for ET-1-mediated constriction in pig coronary arteries (2, 38). ETB is found not only in vascular smooth muscle, where it induces ET-1-mediated constriction but also on the endothelium where they contribute to vasodilation by promoting endothelial release of nitric oxide and prostacyclin (7, 26, 49), as well as clearance of ET-1 via internalization (3). Several studies have shown increased ET-1 levels in the presence of cardiovascular disease states (14, 27, 30) as well as alterations in expression and function of endothelin receptor subtypes (9, 20, 30, 54). Others have reported that exercise training can induce a reduction in plasma ET-1 levels in patients with vascular disease (4, 34, 41). Interestingly, Duncker, Merkus, and colleagues have demonstrated that both systemic and coronary ET-1-induced vasoconstriction in pigs is mediated primarily through ETA and that this response is significantly blunted during acute exercise, particularly in the coronary circulation (5, 36, 38, 39). These findings suggest that the vasoconstrictor effect of ET-1 wanes during acute exercise. However, the adaptations of an extended exercise-training regimen in progressive coronary occlusion to the endothelin system have received limited evaluation.
Given that the number one recommendation for patients with ischemic coronary disease is therapeutic lifestyle changes that include an exercise-training regimen, we sought to determine adaptations in the endothelin system of the coronary vasculature in response to a 14-week exercise-training regimen in a swine model of chronic coronary occlusion. Our laboratory has recently reported exercise training-enhanced ET-1 vasoconstriction in collateral-dependent small coronary arteries mediated by increased Ca2+ sensitization and up-regulation of the PKC signaling pathway (46). To further explore potential underlying mechanisms, we tested the hypothesis that an enhanced role for ETA would contribute to increased endothelin-mediated vasoconstriction in collateral-dependent arteries after a persistent exercise-training regimen.
Materials and Methods
Experimental animals and surgical instrumentation
All animal protocols were approved by the Texas A&M University Institutional Animal Care and Use Committee and conformed to the NIH Guide for Care and Use of Laboratory Animals (NIH publication 85-23, revised 2010). As illustrated in Figure 1, the experimental protocol was initiated when adult female Yucatan miniature swine (6–7 mo of age) were surgically instrumented with an ameroid constrictor around the proximal LCX artery as described previously (21, 22, 24, 25, 46). Animals were pre-anesthetized with glycopyrrolate (0.004 mg·kg−1, i.m.), midazolam (0.5 mg·kg−1, i.m.) and ketamine (20 mg·kg−1, i.m.). Anesthesia was induced with 3% isoflurane. Animals were intubated and anesthesia was maintained with 2–3% isoflurane and supplemental O2 during aseptic surgery. During surgery, animals received the following drugs as necessary: pancuronium (0.1 mg·kg−1; neuromuscular blocker) or vecuronium bromide (0.1 mg·kg−1; neuromuscular blocker) and lidocaine (1 mg·kg−1, i.v.; anti-arrhythmic). Immediately following surgery, pigs received ketofen (3.0 mg·kg−1, i.v.; NSAID). Prior to surgery and during surgical recovery, animals received either buprenorphine hydrochloride (0.1 mg·kg−1, i.v.; analgesic) or butorphanol tartrate (0.5 mg·kg−1, i.v.; analgesic) every 3–6 hr, as needed for pain relief. Antibiotics (ceftiofur 4 mg·kg−1, i.m.) were administered 24 hours before surgery, immediately prior to surgery and for two days following surgery. As indicated in Figure 1, previous studies have demonstrated that gradual narrowing to complete occlusion of the left circumflex coronary artery in this model is achieved generally at about three weeks after surgical placement of the ameroid ring (47). Previous reports have also revealed that collateral development in this model levels off by 7–8 weeks postoperatively (47, 57). For this reason, we allow the animals eight weeks of surgical recovery prior to initiation of the sedentary or exercise training regimen (Figure 1). This recovery period allows us to distinguish collateral development as a result of occlusion alone from that of exercise training in the presence of occlusion.
Figure 1. Time line of experimental protocol.

Miniature swine were instrumented with ameroid constrictors around the proximal LCx artery to initiate the experimental protocol. Gradual narrowing of the LCx typically develops into complete occlusion by around three weeks postoperatively. Animals were allowed eight weeks of surgical recovery before being randomly assigned to the exercise training or sedentary regimens. Following 14 weeks of exercise training or being confined to pens, coronary arteries and myocardium were harvested for functional assessment and additional assays.
Sedentary and exercise protocols
Following surgical recovery, pigs were randomly assigned to either a sedentary or exercise-training group. Exercise-trained (n=30) pigs underwent a progressive treadmill program (5 days/wk for 14 wks) as described previously (11, 46). Speed and duration of the exercise training sessions were progressively increased so that during the last week of training, animals ran at 4–5.5 mph for 60 min and at 6 mph for 5–15 min. Grade of the treadmill was maintained at 0% throughout the experimental protocol. The progressive nature of the exercise training was dependent upon the tolerance of each animal and therefore, ranges of running speed and duration presented represent differing abilities of the animals. Sedentary (n=31) pigs were confined to their pens. Effectiveness of the exercise-training program was determined by comparing heart-to-body weight ratio and skeletal muscle citrate synthase activity as previously described (17, 25).
Preparation of coronary arteries
Following completion of the 14-wk exercise-training protocol or sedentary confinement, pigs were anesthetized using xylazine (2.25 mg·kg−1, i.m.), ketamine (35 mg·kg−1, i.m.) and pentothal sodium (30 mg·kg−1, i.v.), followed by administration of heparin (1000 U·kg−1, i.v.). Pigs were intubated and ventilated with room air and a left lateral thoracotomy was performed in the fourth intercostal space. Hearts were removed, placed in Krebs bicarbonate buffer (0–4 °C) and weighed. Visual inspection of the ameroid occluder during dissection of the LCX artery indicated 100% occlusion in all pigs used for this study. Size-matched arteries (~150 μm luminal diameter) were isolated from myocardial regions distal to both the collateral-dependent LCX (distal to occlusion) and the nonoccluded LAD arteries as previously described (21, 46). Isolated arteries were used for either same day microvascular function studies or flash frozen with liquid nitrogen and stored at −80°C until processed for mRNA or protein quantification.
Microvascular function studies
Arterial rings were studied using specialized isometric microvessel myographs (Danish Myograph Technology) as previously described (21, 46). Briefly, following establishment of optimal vessel length and equilibration, arterial rings were pretreated with endothelin receptor subtype antagonists for 15 min. Subsequently, an ET-1 concentration-response curve was performed by cumulative additions of ET-1 to the tissue bath to achieve the desired concentrations. Control ET-1 curves were also generated in the absence of endothelin receptor antagonists. The contractile response was measured at steady state after addition of each concentration of ET-1. Developed tension (T) was calculated as the millinewton (mN) of force generated (F) per axial vessel length (g; in mm), where T = F/2g (40). The selective inhibitors, BQ123 (ETA inhibitor; 1 μM), BQ788 (ETB inhibitor; 1 μM) or both, were used to assess the contribution of these receptors to the ET-1-mediated tension development. To avoid residual effects of the pharmacologic agents used in these studies only one curve was completed in each arterial segment.
Endogenous endothelin tissue measurements
Myocardial tissue (~200 mg) from collateral-dependent and nonoccluded regions was collected from both sedentary and exercise treatment groups, flash frozen, and stored at −80°C until processed as described previously (14) with modifications. Samples were homogenized in 10X volumes of 0.1 M acetic acid, sonicated, and boiled. The homogenates were centrifuged at 12 g for 10 min at 4°C. Supernatant was analyzed for endothelin content through a commercially available immunometric assay (Endothelin EIA kit; Cayman Chemical) as per manufacturer’s instructions.
Real-time PCR quantification of ETA, ETB, and ECE mRNA
Total RNA was extracted from small coronary arteries (~150 μm luminal diameter; ~5–10 mm total length) isolated from nonoccluded and collateral-dependent myocardial regions of sedentary and exercise-trained groups using Trizol reagent (Invitrogen) according to the manufacturer’s instructions. Total isolated RNA was reverse-transcribed to cDNA using iScript cDNA Synthesis Kit (Bio-Rad), in a final volume of 20 μL. Transcription reactions without reverse transcriptase were performed to verify that DNA contamination was below the level of detection. Real-time quantitative PCR was performed using CFX96 Touch Thermal Cycler (Bio-Rad). Primers for swine ETA, ETB, and ECE were selected from a previous report (14). Quantitative real-time RT-PCR was performed using iQ SYBR Green Supermix (5 μL; Bio-Rad), sense and anti-sense primers (5 pmol each), water (2 μL), cDNA (2 μL) in 10 μL of total reaction volume. The real-time PCR protocol that was employed included initial denaturation for 5 min at 95°C, 40 cycles of 95°C for 10 s and 60°C for 20 s, followed by a melting step with a slow heating from 55 to 95°C with a rate of 0.05°C/s. All samples per investigated gene were detected in one run to eliminate inter-assay variance and each sample was amplified in triplicate for each gene. Real-time efficiency for each primer set was acquired by amplification of a standardized cDNA dilution series. The specificity of the amplified PCR products was verified by analysis of the melting curve, which is sequence-specific and by agarose gel electrophoresis to confirm detection of a single product. GAPDH was used to normalize the amount of mRNA. The relative amount of the target genes isolated from each myocardial region was calculated using the 2−ΔΔCT method and expressed relative to the amount from the nonoccluded myocardial region of sedentary pigs.
Immunoblots
Additional coronary arteries (~150 μm; 6–10 mm total length) were dissected from both the nonoccluded and collateral-dependent myocardial regions, quick-frozen in liquid N2 and stored at −80°C for later immunoblot analysis. Arteries were homogenized in 40 μl of 2X lysis buffer (20 mM Tris-HCl, 50 mM NaCl, 3 mM EGTA, 0.1%Triton-X100, 1% protease and 1% phosphatase inhibitor cocktails by freeze-thaw cycles and vortexed ~6–8 times. Protein concentration was determined by BCA protein assay kit (Thermo Scientific Pierce). Arterial lysate (10 μg of total protein) was subjected to 10 % SDS-polyacrylamide gel electrophoresis, transferred to PVDF membranes, and probed overnight with primary antibody. Primary antibody dilutions were as follows: ETA (1:250), ETB (1:200), and GAPDH (1:5,000) at 4°C overnight. After washing, membranes were incubated with the appropriate horseradish peroxidase-conjugated species-specific anti-IgG (1:50,000–1:100,000 depending on primary antibody) for two hours at 25°C. Peroxidase activity was detected using SuperSignal West Dura Substrate. Scanning densitometry was used to quantify signal density from luminograms. Normalization for potential loading differences was accomplished using the ratio of densitometry signals for the receptor protein to GAPDH.
Solutions and drugs
Krebs bicarbonate buffer contained (in mM) 131.5 NaCl, 5 KCl, 1.2 NaH2PO4, 1.2 MgCl2, 2.5 CaCl2, 11.2 glucose, 13.5 NaHCO3, and 0.025 EDTA. All drugs were obtained from Sigma Chemical unless otherwise noted. Endothelin-1 was purchased from Bachem. BQ123 was purchased from EMD Millipore and BQ788 was purchased from American Peptide Company. Primary antibodies directed against the following proteins were utilized for these studies: ETA (sc-33536) and ETB (sc-33537; sc-21199; sc-21196) receptors from Santa Cruz Biotechnology, ETB (ab50658) from Abcam, and GAPDH (RGM2-200) from Advanced Immunochemical.
Data analysis
Endothelin levels in myocardial samples and real time PCR and immunoblot data were analyzed using two-way ANOVA. Concentration-response relationships were analyzed using repeated-measures two-way ANOVA. When a significant main effect was identified by ANOVA, mean differences were ascertained using Bonferroni correction for multiple comparisons. Apparent ET-1 EC50 was calculated based on previously reported mathematical calculations (1). When more than one coronary arterial ring from the nonoccluded or collateral-dependent region of a given animal was used in identical protocols, the responses from those rings were averaged before data analyses were conducted. Body weight, heart-to-body weight ratio, citrate synthase values, dimensional characteristics of coronary arterial rings, and EC50 values were analyzed using Student’s t-test. For all analyses, a P value of ≤ 0.05 was considered significant. Data are presented as means ± SEM, and n values reflect the number of pigs studied.
Results
Efficacy of the exercise-training program
The effectiveness of the 14-wk exercise-training program was demonstrated by a significant increase in the heart-to-body weight ratio and increased skeletal muscle oxidative enzyme activity in exercise-trained compared with sedentary animals (Table 1). Although body weight did not differ between sedentary and exercise-trained animals at the time of death, the heart-to-body weight ratio was significantly greater in exercise-trained compared with sedentary pigs. Citrate synthase activity increased significantly in the deltoid muscle and the medial and long heads of the triceps brachii muscle in exercise-trained compared with sedentary pigs.
Table 1.
Efficacy of the exercise-training program
| CS Activity (μmol·min−1·g−1) | |||||
|---|---|---|---|---|---|
|
| |||||
| BW (kg) | HW/BW (g/kg) | DM | TMH | TLH | |
| Sedentary (n = 31) | 35.1 ± 0.9 | 4.43 ± 0.09 | 37.2 ± 1.3 | 36.0 ± 1.5 | 31.3 ± 1.4 |
| Exercise (n = 30) | 33.6 ± 0.7 | 5.31 ± 0.12* | 45.7 ± 1.6* | 44.4 ± 2.0* | 36.8 ± 1.6* |
Values are mean ± S.E.M. Numbers in parentheses represent number of animals; CS, citrate synthase; BW, body weight; HW/BW, heart-to-body weight ratio; DM, deltoid muscle; TMH, triceps medial head; TLH, triceps long head
P<0.05 vs. sedentary.
Coronary artery dimensions and characteristics
No significant differences in dimensional characteristics were observed between arterial rings from the nonoccluded or collateral-dependent regions of either sedentary or exercise-trained animals (Table 2).
Table 2.
Coronary artery dimensions and characteristics
| ED (μm) | ID (μm) | WT (μm) | AL (mm) | RT L95 (mN/mm) | |
|---|---|---|---|---|---|
| Sedentary (n = 31) | |||||
| nonoccluded | 240 ± 7 | 151 ± 7 | 44 ± 1 | 1.52 ± 0.02 | 0.50 ± 0.04 |
| collateral-dependent | 246 ± 7 | 135 ± 9 | 45 ± 1 | 1.52 ± 0.02 | 0.62 ± 0.07 |
| Exercise (n = 30) | |||||
| nonoccluded | 240 ± 8 | 158 ± 6 | 47 ± 1 | 1.51 ± 0.02 | 0.45 ± 0.02 |
| collateral-dependent | 262 ± 9 | 179 ± 9 | 45 ± 1 | 1.51 ± 0.02 | 0.58 ± 0.07 |
Values are mean ± S.E.M. Numbers in parentheses represent number of animals; ED, external diameter; ID, internal diameter; WT, wall thickness; AL, axial length; RT L95, arterial resting tension (RT) where L95=0.95*L100 and L100 is the internal circumference that the artery would have under a transmural pressure of 100 mmHg, as previously (23). No significant differences exist.
ET-1 concentration-response curves
We examined concentration-dependent contractile responses to ET-1 in small coronary arterial rings isolated from the nonoccluded and collateral-dependent regions of sedentary and exercise-trained pigs. In sedentary animals, contractile responses to ET-1 were not different in arteries isolated from the collateral-dependent compared with the nonoccluded region (Fig 2A). In contrast, exercise training induced significantly enhanced ET-1-mediated contractile response in collateral-dependent compared to nonoccluded arteries (Fig 2B). Similarly, EC50 data revealed that exercise training increased the sensitivity to ET-1 in collateral-dependent compared with nonoccluded arteries (Table 3; no inhibitor column).
Figure 2. Endothelin-1 concentration-response relationships.
ET-1 concentration-response curves between nonoccluded and collateral-dependent arteries in sedentary (A) and exercise-trained (B) pigs. Concentration-response curves for ET-1 were truncated at the concentration (3 nM) because arteries generally displayed reduced ET-1-mediated contraction at subsequent concentrations. A subset of these data has been published previously (46). * P < 0.05; n in parentheses equals number of animals.
Table 3.
Apparent EC50 values for ET-1 -mediated constriction in the absence and presence of inhibition of select endothelin receptor subtypes
| Group | No inhibitors | BQ123 | BQ788 | BQ123 + BQ788 |
|---|---|---|---|---|
| Sedentary | (n=14–16) | (n=9) | (n=7) | (n=6) |
| nonoccluded | −8.65 ± 0.02 | −8.67 ± 0.02 | −8.52 ± 0.02* | −8.43 ± 0.05* |
| collateral-dependent | −8.61 ± 0.03 | −8.68 ± 0.02* | −8.63 ± 0.03† | −8.45 ± 0.02* |
| Exercise-Trained | (n=13–14) | (n=10) | (n=7) | (n=6) |
| nonoccluded | −8.61 ± 0.03 | −8.67 ± 0.02 | −8.63 ± 0.05 | −8.52 ± 0.06 |
| collateral-dependent | −8.76 ± 0.06† | −8.72 ± 0.04 | −8.69 ± 0.04 | −8.53 ± 0.03* |
Values (log M) are means ± SEM. n values represent number of animals studied and are indicated in parentheses under column headers.
P<0.05 vs. corresponding EC50 from control (no inhibitors).
P<0.05 vs. corresponding EC50 from nonoccluded artery.
ET-1 concentration-response curves in the presence of endothelin receptor inhibition
The effect of endothelin receptor antagonism on ET-1-mediated tension development was compared in arteries isolated from the nonoccluded and collateral-dependent myocardial regions of sedentary and exercise-trained pigs. Arteries were pretreated with antagonists for ETA (BQ123; 1 μM) or ETB (BQ788; 1 μM) or combined receptor antagonism. As illustrated in Fig 3A, inhibition of either ETA or ETB significantly attenuated the ET-1 contractile response in arteries from the nonoccluded region of sedentary pigs. These findings indicate that the ET-1 contractile response is mediated through both ETA and ETB. Inhibiting both receptors simultaneously decreased the ET-1 response to a significantly greater degree compared with single receptor antagonism. In collateral-dependent arteries of sedentary pigs (Fig 3B), single blockade of either ETA or ETB, had a negligible effect on the contractile response to ET-1; however, dual blockade significantly decreased ET-1 contractile responses compared with no inhibitors or with single receptor blockade.
Figure 3. Effect of endothelin receptor subtype inhibition on endothelin-1-mediated constriction.
ET-1 concentration-response curves were examined in the absence of any inhibitors or in the presence of BQ123 (1 μM), BQ788 (1 μM), or combined antagonism in nonoccluded (nonocc) and collateral-dependent (coll-dep) arteries from sedentary and exercise-trained pigs. * P < 0.05 compared with no inhibitor. † P < 0.05 compared with BQ788. ‡ < 0.05 compared with BQ123. n in parentheses equals number of animals.
We also completed receptor inhibition studies in nonoccluded and collateral-dependent arteries of exercise-trained pigs. As revealed in Fig 3C, inhibition of either ETA or ETB did not significantly reduce the contractile response to ET-1 in arteries from the nonoccluded myocardial region; however, dual blockade significantly decreased this response when compared with no inhibitors. In collateral-dependent arteries of exercise-trained pigs (Fig 3D), blockade of ETA significantly attenuated the ET-1 response. Conversely, blockade of ETB did not alter the ET-1 contractile response. Simultaneous inhibition of ETA and ETB decreased the ET-1 response to a degree not statistically different from that of single blockade of ETA and to a significantly greater extent compared to blockade of ETB alone.
ETA, ETB, and ECE mRNA expression
To determine the effects of occlusion and exercise training on the mRNA expression of the endothelin receptor subtypes and ECE, we performed quantitative RT-PCR experiments on small coronary arteries isolated from the nonoccluded and collateral-dependent myocardial regions from both sedentary and exercise-trained pigs. These experiments demonstrated that the mRNA expression levels of ETA (Fig 4A), ETB (Fig 4B), and ECE (Fig 4C) were not significantly altered by chronic coronary artery occlusion or exercise training.
Figure 4. Effects of chronic occlusion and exercise training on mRNA expression of endothelin receptor subtypes A and B and endothelin converting enzyme.

Expression of ETA, ETB, and ECE mRNA was not altered significantly by chronic occlusion or exercise training. Values are means ± S.E.M. of the number of animals indicated in parentheses and reported relative to expression level in nonoccluded arteries of sedentary pigs (SED nonoccl).
ETA and ETB protein content
We examined the protein levels of the ETA receptor subtype in nonoccluded and collateral-dependent arteries from sedentary and exercise-trained pigs as shown by the immunoblot image of ETA with GAPDH as loading control (Fig 5A). These experiments revealed that ETA protein levels were not altered significantly by occlusion or exercise training (Fig 5A). We also initiated studies to examine protein levels of the ETB receptor subtype. In preliminary studies, we discovered that while we were able to detect ETB receptor protein in pig lung, the protein levels of ETB receptor in pig arteries were of very low abundance and not detectable via immunoblot, even when the total protein load for the coronary arteries was increased to 40 μg (Fig 5B). Although four ETBR antibodies were screened as indicated in the methods section, results of one representative trial (Santa Cruz no. sc-33537) are shown in Figure 5B.
Figure 5. Effect of chronic occlusion and exercise training on protein levels of endothelin receptor subtypes.

Evaluation across artery treatment groups revealed that neither occlusion nor exercise training produced significant alterations in ETAR protein levels. Assessment of ETBR protein revealed that ETBR content in coronary arteries was below the level detectable by immunoblot. Protein was quantified by densitometry analysis, normalized to GAPDH, and expressed relative to the density of nonoccluded arteries of sedentary pigs. SED nonocc, lanes 1, 3, 9, 15, 19, 21; SED coll-dep, lanes 2, 4, 10, 16, 20, 22; EX nonocc, lanes 5, 7, 11, 13, 17, 23; EX coll-dep, lanes 6, 8, 12, 14, 18, 24. PL, pig lung; PA, pig artery. Values are means ± S.E.M. of the number of animals indicated.
Regional tissue endothelin levels
Endothelin levels were measured in tissue sections from both nonoccluded and collateral-dependent myocardial regions. These experiments revealed that exercise training significantly elevated regional endothelin levels when compared to sedentary pigs, independent of chronic coronary occlusion (Fig 6).
Figure 6. Effects of chronic occlusion and exercise training on regional myocardial endothelin levels.
Myocardial endothelin levels were increased after exercise training in both nonoccluded (nonocc) and collateral-dependent (coll-dep) myocardial regions. * P < 0.05 compared with nonocc myocardial regions of SED pigs. † P < 0.05 compared with coll-dep myocardial regions of SED pigs. n in parentheses equals number of animals.
Discussion
Alterations to the endothelin system in cardiovascular disease states have been examined previously and have formed the basis for the use of endothelin receptor antagonists clinically. However, clinical outcomes with the use of such pharmacological agents have resulted in variable degrees of success depending on the cardiovascular disease targeted (reviewed in (29, 31, 45)). Few studies have evaluated the combined effects of chronic coronary occlusion and the implementation of a progressive exercise-training regimen on this system (46). Results of the current study reveal several key novel findings that highlight unique vascular adaptations pertaining to the endothelin system in small coronary arteries of an ischemic heart disease animal model. We demonstrate that in nonoccluded arteries of sedentary pigs, single endothelin receptor inhibition of either receptor subtype significantly reduces the ET-1 contractile response to comparable levels suggesting that in these vessels both receptors contribute similarly to ET-1 vasoconstriction. We also show that although the ET-1 responses in collateral-dependent arteries are similar to their nonoccluded counterparts under control conditions, individual endothelin receptor antagonism has little effect on the ET-1 contractile responses. These data suggest an occlusion-mediated increase in compensation by the functionally active receptor after inhibition of either ETA or ETB. In addition, we demonstrate that in collateral-dependent arteries, exercise training produces a disproportionate increase in the ETA contribution to the ET-1 contractile response with negligible contribution by ETB. Finally, these functional adaptations occurred without significant changes in endothelin receptor mRNA expression and ETA protein content but with significant increases in endothelin levels of both nonoccluded and collateral-dependent myocardial regions in exercise-trained pigs.
Our findings in the different arterial treatment groups evaluated in this porcine model indicate that there may be a significant degree of “cross-talk” or compensation by the endothelin receptor subtypes. This concept of compensation has been previously described as the limited ability of a blocked endothelin receptor subtype to decrease an endothelin-mediated response due to compensation by the other functionally active receptor (8, 43). In sedentary pigs, it is clear that single antagonism of either ETA or ETB results in a significant decrease in the ET-1 contractile response in nonoccluded (Fig 3A) but not collateral-dependent (Fig 3B) arteries. Furthermore, combined inhibition of both receptor subtypes nearly abolished contraction in both nonoccluded and collateral-dependent arteries. Taken together, these data suggest that the receptor subtypes in collateral-dependent arteries reveal a unique adaptation in that the functionally active receptor appears to effectively compensate upon single receptor antagonism of ETA or ETB. Similar compensatory interactions by the endothelin receptor subtypes have been previously reported in small pulmonary resistance arteries isolated from a rat model of myocardial infarction (50, 51). It is possible that this synergistic inhibition with dual receptor antagonism is due to a functional heterodimerization between ETA and ETB as previously suggested in other disease states, such as pulmonary arterial hypertension (12). Indeed, endothelin receptors have been shown to form heterodimers (10, 13, 16) and it has been suggested that the pharmacology of these receptors may differ from that of monomers (55), potentially requiring both selective ETA and ETB receptor antagonists to inhibit the function of the heterodimeric receptor (35). However, a role for heterodimers in the coronary vasculature of our model is speculative as the basic understanding of endothelin receptor functional heterodimerization is a relatively novel concept and thus limited (55). Nevertheless, our finding in collateral-dependent arteries provides support for consideration of the use of dual endothelin receptor antagonism clinically rather than selective inhibition in patients with ischemic coronary disease in an attempt to improve blood flow to compromised myocardium. Indeed, various studies have reported the benefits of the use of dual endothelin receptor antagonism in coronary artery disease patients (32, 56).
Evaluation of the ET-1 contractile response in arteries from the nonoccluded regions in exercise-trained pigs (Fig 3C) revealed that single antagonism of either ETA or ETB did not significantly reduce the ET-1 contractile response, while dual antagonism significantly attenuated ET-1-mediated contraction. These findings are statistically similar to that observed in the collateral-dependent arteries of sedentary pigs, although the impact of dual receptor antagonism did not appear as extensive in the nonoccluded arteries of exercise-trained pigs (Fig 3B). The basis for the slightly more persistent contraction in the presence of dual receptor antagonism is unknown. The ET-1 contractile response of arteries from the collateral-dependent region in exercise-trained pigs (Fig 3D) was unique in that inhibition of ETA resulted in a significant decrease in the ET-1 contractile response whereas inhibition of ETB did not alter ET-1 contraction. While it appears that simultaneous ETA and ETB blockade inhibited the ET-1 response even further than ETA blockade alone, this comparison did not achieve statistical significance. Despite the lack of statistical difference, the greater effect of dual receptor antagonism than ETA blockade alone suggests that ETB may play a role during ETA antagonism. Notably, these adaptations were exclusive to these arteries, indicating that the combination of occlusion and exercise training stimulated novel changes that were not observed with occlusion or exercise training alone.
A multitude of studies have highlighted increases in coronary blood flow when an exercise-training regimen is implemented in patients (18, 19, 52, 58) and animal models with ischemic coronary disease (6, 48). Bloor and colleagues measured regional myocardial blood flow distribution in a similar porcine model of chronic coronary artery occlusion and exercise training (48). In these studies, blood flow into the collateral-dependent region during exercise was significantly increased in the subendocardium, midmyocardium, and subepicardium after the exercise training regimen compared with pre-training levels (48). Accordingly, the exercise-trained animals also displayed enhanced regional left ventricular wall thickening during exercise relative to pre-training levels. Pigs that remained sedentary did not demonstrate significant changes in blood flow or myocardial contractility in the collateral-dependent region over the same time period (48). Enhanced blood flow into the collateral-dependent region would be mediated through growth of the collateral circulation and/or structural/functional adaptations in the microcirculation of the collateral-dependent region. Thus, it is difficult to reconcile the enhanced ET-1/ETA contractile response in collateral-dependent arteries of exercise-trained pigs with the observation of increased blood flow into that region of this porcine model. In a previous report, use of an ETA receptor blocker revealed that endogenous endothelin contributed to coronary vascular tone under resting conditions in a porcine model (38). Interestingly, during acute exercise, the vasoconstrictor influence of endogenous endothelin on the coronary vasculature decreased (38). These investigators proposed that ETA receptor sensitivity to endothelin may have decreased during exercise through an increase in nitric oxide production, which can directly modulate the binding of endothelin to the ETA receptor (38). Indeed, we have previously reported that NOS inhibition results in a significant increase in sensitivity (EC50) to ET-1 in collateral-dependent but not nonoccluded arteries of exercise-trained pigs (46). These data are consistent with our more recent findings that eNOS protein is significantly increased in collateral-dependent compared with nonoccluded arteries of exercise-trained pigs (23). We have also reported enhanced bradykinin-mediated relaxation in collateral-dependent arteries of exercise-trained pigs that is reversed by NOS inhibition (23). Furthermore, others have reported that nitric oxide synthase inhibition decreases blood flow into the collateral-dependent region more so during exercise than at rest (53), providing evidence that the contribution of nitric oxide increases as coronary metabolic demand rises in the compromised myocardial region. Thus, we propose that the adaptive response of enhanced ET-1/ETA contraction in collateral-dependent arteries of exercise-trained pigs may serve to oppose increased nitric oxide signaling and thereby, maintain coronary vascular resistance under resting conditions. Accordingly, as metabolic demand increases with exercise, enhanced nitric oxide production may function to overcome ET-1/ETA contraction and thereby, promote perfusion into the compromised myocardial region.
Despite functional adaptations in the endothelin receptors, our data indicate that there were no significant changes to endothelin receptor or ECE mRNA expression (Fig 4) or ETA protein levels (Fig 5A) between treatment groups. These data suggest that adaptations in the contribution of endothelin receptors to ET-1 contractile responses with occlusion and exercise training may result from adaptations in receptor interaction with the downstream signaling mechanisms rather than changes in receptor density. Indeed, our previous study documented an increased contribution of the PKC signaling pathway to ET-1-mediated contraction as well as enhanced Ca2+ sensitization in collateral-dependent arteries from exercise-trained pigs (46). Taken together, our previous and current findings suggest that exercise training increases ET-1-mediated Ca2+ sensitization in collateral-dependent small coronary arteries likely by way of an enhanced ETA/PKC signaling pathway that leads to augmented contractile responses. In addition, the functional vascular adaptations observed in exercise-trained pigs occurred concurrently with increased regional levels of endothelin. Therefore, collateral-dependent small coronary arteries of exercise-trained pigs, in addition to the disproportionately enhanced contribution of ETA to the ET-1-mediated contractile response, are also exposed to higher endothelin levels than regionally matched vessels from the sedentary control group. Such conditions have been shown to induce endothelin receptor desensitization (15), although this phenomenon was not tested in the current study. We did not see an elevation in endothelin levels in collateral-dependent myocardial regions of sedentary pigs, although others have reported increased plasma endothelin levels in sedentary porcine models of coronary thrombosis (54) and acute myocardial infarction (37). However, the rapid induction of these previously studied disease states may differentially alter endothelin levels compared to that observed with the progressive nature of the coronary occlusion used for the current study (59). Additionally, it is possible that these acute coronary injury models produce adaptations that would potentially change over the time course associated with our chronic disease model.
Conclusions
Our studies reveal that the enhanced ET-1-induced contractile response in collateral-dependent arteries after exercise training appears to be mediated by an enhanced contribution subtype. These adaptations of the ETA receptor subtype with little involvement from the ETB protein occurred independently of changes in ETA and ETB receptor mRNA expression or ETA levels. Taken together with our previous data (46), these findings suggest that upregulation of a receptor, such as that mediated by PKC, may be the signaling pathway initiated at the ETA primary mechanism underlying exercise training-enhanced ET-1 contractile responses in collateral-dependent arteries. Previous data from our laboratory also demonstrate enhanced vasodilatory mechanisms in these small collateral-dependent arteries of exercise-trained pigs (23, 46), suggesting adaptations in both vasoconstrictor and vasodilator pathways that may interact to optimize control of coronary blood flow into the compromised myocardium.
Perspective
After ET-1 was discovered and characterized as a potent vasoconstrictor, its role in various cardiovascular diseases was evident, eventually leading to the development of endothelin receptor antagonists. Unfortunately, these agents have not had the degree of clinical success that was initially expected in diseases like heart failure (28, 33, 42). However, there have been encouraging findings in patients with atherosclerotic coronary disease (44). One important clinical implication that we can derive from the current study is that by understanding adaptations in endothelin signaling mechanisms in response to chronic occlusion and exercise training, we can tailor anti-endothelin medications in order to achieve a more desirable outcome for the patient. For example, endothelin receptor antagonists could be used acutely to prevent endothelin-mediated vasomotor reactivity. As the patient implements an exercise-training regimen, these could be fazed out in order to allow for exercise-mediated adaptations in the compromised myocardium that may be hindered in the presence of endothelin receptor antagonists. Further studies are needed to validate this proposed concept.
Acknowledgments
We appreciate the technical expertise of Mildred Mattox and Jeff Bray. These studies were supported by National Institutes of Health grants R01-HL064931 (C.L. Heaps) and T32-RR031229 (A.B. Kier).
Abbreviations
- EC50
agonist concentration producing 50% of the maximal contractile response
- ECE
endothelin converting enzyme
- ETA
endothelin receptor subtype A
- ETB
endothelin receptor subtype B
- ET-1
endothelin-1
- LAD
left anterior descending coronary artery
- LCX
left circumflex coronary artery
- NIH
National Institutes of Health
- NSAID
nonsteroidal anti-inflammatory drug
- PVDF
polyvinylidene fluoride
Footnotes
Disclosures
No conflicts of interest, financial or otherwise, are declared by the authors.
References
- 1.Alexander B, Browse DJ, Reading SJ, Benjamin IS. A simple and accurate mathematical method for calculation of the EC50. J Pharmacol Toxicol Methods. 1999;41:55–58. doi: 10.1016/s1056-8719(98)00038-0. [DOI] [PubMed] [Google Scholar]
- 2.Awane-Igata Y, Ikeda S, Watanabe T. Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br J Pharmacol. 1997;120:516–522. doi: 10.1038/sj.bjp.0700925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, Webb DJ, Kotelevtsev YV. Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension. 2006;48:286–293. doi: 10.1161/01.HYP.0000229907.58470.4c. [DOI] [PubMed] [Google Scholar]
- 4.Beck DT, Casey DP, Martin JS, Emerson BD, Braith RW. Exercise training improves endothelial function in young prehypertensives. Exp Biol Med. 2013;238:433–441. doi: 10.1177/1535370213477600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.De Beer VJ, Bender SB, Taverne YJ, Gao F, Duncker DJ, Laughlin MH, Merkus D. Exercise limits the production of endothelin in the coronary vasculature. Am J Physiol Heart Circ Physiol. 2011;300:H1950–H1959. doi: 10.1152/ajpheart.00954.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bloor CM, White F, Sanders T. Effects of exercise on collateral development in myocardial ischemia in pigs. J Appl Physiol. 1984;56:656–665. doi: 10.1152/jappl.1984.56.3.656. [DOI] [PubMed] [Google Scholar]
- 7.Callera G, Tostes R, Savoia C, Muscara MN, Touyz RM. Vasoactive peptides in cardiovascular (patho)physiology. Expert Rev Cardiovasc Ther. 2007;5:531–552. doi: 10.1586/14779072.5.3.531. [DOI] [PubMed] [Google Scholar]
- 8.Clozel M, Flores S. Endothelin receptors as drug targets in chronic cardiovascular diseases: the rationale for dual antagonism. Drug Dev Res. 2006;67:825–834. [Google Scholar]
- 9.Dagassan PH, Breu V, Clozel M, Künzli A, Vogt P, Turina M, Kiowski W, Clozel JP. Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol. 1996;27:147–153. doi: 10.1097/00005344-199601000-00023. [DOI] [PubMed] [Google Scholar]
- 10.Dai X, Galligan JJ. Differential trafficking and desensitization of human ET(A) and ET(B) receptors expressed in HEK 293 cells. Exp Biol Med. 2006;231:746–751. [PubMed] [Google Scholar]
- 11.Deer RR, Heaps CL. Exercise training enhances multiple mechanisms of relaxation in coronary arteries from ischemic hearts. Am J Physiol Heart Circ Physiol. 2013;305:H1321–H1331. doi: 10.1152/ajpheart.00531.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dupuis J. Endothelin: setting the scene in PAH. Eur Respir Rev. 2007;16:3–7. [Google Scholar]
- 13.Evans NJ, Walker JW. Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J. 2008;95:483–492. doi: 10.1529/biophysj.107.119206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Forni M, Mazzola S, Ribeiro LA, Pirrone F, Zannoni A, Bernardini C, Bacci ML, Albertini M. Expression of endothelin-1 system in a pig model of endotoxic shock. Regul Pept. 2005;131:89–96. doi: 10.1016/j.regpep.2005.07.001. [DOI] [PubMed] [Google Scholar]
- 15.Gärtner F, Seidel T, Schulz U, Gummert J, Milting H. Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation. J Biol Chem. 2013;288:32138–32148. doi: 10.1074/jbc.M113.461566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gregan B, Jürgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem. 2004;279:27679–27687. doi: 10.1074/jbc.M403601200. [DOI] [PubMed] [Google Scholar]
- 17.Griffin KL, Woodman CR, Price EM, Laughlin MH, Parker JL. Endothelium-mediated relaxation of porcine collateral-dependent arterioles is improved by exercise training. Circulation. 2001;104:1393–1398. doi: 10.1161/hc3601.094274. [DOI] [PubMed] [Google Scholar]
- 18.Hambrecht R, Adams V, Erbs S, Linke A, Kränkel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation. 2003;107:3152–3158. doi: 10.1161/01.CIR.0000074229.93804.5C. [DOI] [PubMed] [Google Scholar]
- 19.Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342:454–460. doi: 10.1056/NEJM200002173420702. [DOI] [PubMed] [Google Scholar]
- 20.Hasdai D, Mathew V, Schwartz RS, Smith LA, Holmes DR, Katusic ZS, Lerman A. Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia. Arter Thromb Vasc Biol. 1997;17:2737–2743. doi: 10.1161/01.atv.17.11.2737. [DOI] [PubMed] [Google Scholar]
- 21.Heaps CL, Mattox ML, Kelly KA, Meininger CJ, Parker JL. Exercise training increases basal tone in arterioles distal to chronic coronary occlusion. Am J Physiol Heart Circ Physiol. 2006;290:H1128–H1135. doi: 10.1152/ajpheart.00973.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Heaps CL, Parker JL, Sturek M, Bowles DK. Altered calcium sensitivity contributes to enhanced contractility of collateral-dependent coronary arteries. J Appl Physiol. 2004;97:310–316. doi: 10.1152/japplphysiol.01400.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Heaps CL, Robles JC, Sarin V, Mattox ML, Parker JL. Exercise training-induced adaptations in mediators of sustained endothelium-dependent coronary artery relaxation in a porcine model of ischemic heart disease. Microcirculation. 2014;21:388–400. doi: 10.1111/micc.12116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Heaps CL, Sturek M, Price EM, Laughlin MH, Parker JL. Sarcoplasmic reticulum Ca(2+) uptake is impaired in coronary smooth muscle distal to coronary occlusion. Am J Physiol Heart Circ Physiol. 2001;281:H223–H231. doi: 10.1152/ajpheart.2001.281.1.H223. [DOI] [PubMed] [Google Scholar]
- 25.Heaps CL, Sturek M, Rapps JA, Laughlin MH, Parker JL. Exercise training restores adenosine-induced relaxation in coronary arteries distal to chronic occlusion. Am J Physiol Heart Circ Physiol. 2000;278:H1984–H1992. doi: 10.1152/ajpheart.2000.278.6.H1984. [DOI] [PubMed] [Google Scholar]
- 26.Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest. 1993;91:1367–1373. doi: 10.1172/JCI116338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Kähler J, Ewert A, Weckmüller J, Stobbe S, Mittmann C, Köster R, Paul M, Meinertz T, Münzel T. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol. 2001;38:49–57. doi: 10.1097/00005344-200107000-00006. [DOI] [PubMed] [Google Scholar]
- 28.Kaluski E, Kobrin I, Zimlichman R, Marmor A, Krakov O, Milo O, Frey A, Kaplan S, Krakover R, Caspi A, Vered Z, Cotter G. RITZ-5: randomized intravenous tezosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol. 2003;41:204–210. doi: 10.1016/s0735-1097(02)02708-0. [DOI] [PubMed] [Google Scholar]
- 29.Kaoukis A, Deftereos S, Raisakis K, Giannopoulos G, Bouras G, Panagopoulou V, Papoutsidakis N, Cleman MW, Stefanadis C. The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition. Curr Top Med Chem. 2013;13:95–114. doi: 10.2174/1568026611313020003. [DOI] [PubMed] [Google Scholar]
- 30.Katwa LC, Campbell SE, Tanner MA, Myers PR. The upregulation of endothelin and its receptors in porcine coronary arteries in a double balloon injury model of restenosis. Basic Res Cardiol. 1999;94:445–453. doi: 10.1007/s003950050160. [DOI] [PubMed] [Google Scholar]
- 31.Kirkby NS, Hadoke PWF, Bagnall AJ, Webb DJ. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? Br J Pharmacol. 2008;153:1105–1119. doi: 10.1038/sj.bjp.0707516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Krishnan U, Win W, Fisher M. First report of the successful use of bosentan in refractory vasospastic angina. Cardiology. 2010;116:26–28. doi: 10.1159/000313365. [DOI] [PubMed] [Google Scholar]
- 33.Luscher TF. Hemodynamic and neurohumoral effects of selective endothelin A (ETA) receptor blockade in chronic heart failure: the heart failure ETA receptor blockade trial (HEAT) Circulation. 2002;106:2666–2672. doi: 10.1161/01.cir.0000038497.80095.e1. [DOI] [PubMed] [Google Scholar]
- 34.Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, Kuno S, Ajisaka R, Yamaguchi I, Matsuda M. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol. 2003;95:336–341. doi: 10.1152/japplphysiol.01016.2002. [DOI] [PubMed] [Google Scholar]
- 35.Mazzuca MQ, Khalil Ra. Vascular endothelin receptor type B: structure, function and dysregulation in vascular disease. Biochem Pharmacol. 2012;84:147–162. doi: 10.1016/j.bcp.2012.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Merkus D, Duncker DJ, Chilian WM. Metabolic regulation of coronary vascular tone: role of endothelin-1. Am J Physiol Heart Circ Physiol. 2002;283:H1915–H1921. doi: 10.1152/ajpheart.00223.2002. [DOI] [PubMed] [Google Scholar]
- 37.Merkus D, Houweling B, van den Meiracker AH, Boomsma F, Duncker DJ. Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol. 2005;288:H871–H880. doi: 10.1152/ajpheart.00429.2004. [DOI] [PubMed] [Google Scholar]
- 38.Merkus D, Houweling B, Mirza A, Boomsma F, van den Meiracker AH, Duncker DJ. Contribution of endothelin and its receptors to the regulation of vascular tone during exercise is different in the systemic, coronary and pulmonary circulation. Cardiovasc Res. 2003;59:745–754. doi: 10.1016/s0008-6363(03)00479-6. [DOI] [PubMed] [Google Scholar]
- 39.Merkus D, Sorop O, Houweling B, Boomsma F, van den Meiracker AH, Duncker DJ. NO and prostanoids blunt endothelin-mediated coronary vasoconstrictor influence in exercising swine. Am J Physiol Heart Circ Physiol. 2006;291:H2075–H2081. doi: 10.1152/ajpheart.01109.2005. [DOI] [PubMed] [Google Scholar]
- 40.Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19–26. doi: 10.1161/01.res.41.1.19. [DOI] [PubMed] [Google Scholar]
- 41.Nyberg M, Mortensen SP, Hellsten Y. Physical activity opposes the age-related increase in skeletal muscle and plasma endothelin-1 levels and normalizes plasma endothelin-1 levels in individuals with essential hypertension. Acta Physiol. 2013;207:524–535. doi: 10.1111/apha.12048. [DOI] [PubMed] [Google Scholar]
- 42.O’Connor CM, Gattis WA, Adams KF, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M. Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the randomized intravenous tezosentan study (RITZ-4) J Am Coll Cardiol. 2003;41:1452–1457. doi: 10.1016/s0735-1097(03)00194-3. [DOI] [PubMed] [Google Scholar]
- 43.Rapoport RM, Zuccarello M. Endothelin(A)-endothelin(B) receptor cross talk in endothelin-1-induced contraction of smooth muscle. J Cardiovasc Pharmacol. 2012;60:483–494. doi: 10.1097/FJC.0b013e31826f32c1. [DOI] [PubMed] [Google Scholar]
- 44.Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010;122:958–966. doi: 10.1161/CIRCULATIONAHA.110.967406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rich S, McLaughlin VV. Endothelin receptor blockers in cardiovascular disease. Circulation. 2003;108:2184–2190. doi: 10.1161/01.CIR.0000094397.19932.78. [DOI] [PubMed] [Google Scholar]
- 46.Robles JC, Sturek M, Parker JL, Heaps CL. Ca2+ sensitization and PKC contribute to exercise training-enhanced contractility in porcine collateral-dependent coronary arteries. Am J Physiol Heart Circ Physiol. 2011;300:H1201–H1209. doi: 10.1152/ajpheart.00957.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Roth D, Maruoka Y, Rogers J, White F, Longhurst J, Bloor CM. Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium. Am J Physiol Heart Circ Physiol. 1987;253:H1279–H1288. doi: 10.1152/ajpheart.1987.253.5.H1279. [DOI] [PubMed] [Google Scholar]
- 48.Roth D, White F, Nichols ML, Dobbs SL, Longhurst JC, Bloor CM. Effect of long-term exercise on regional myocardial function and coronary collateral development after gradual coronary artery occlusion in pigs. Circulation. 1990;82:1778–1789. doi: 10.1161/01.cir.82.5.1778. [DOI] [PubMed] [Google Scholar]
- 49.Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325–415. [PubMed] [Google Scholar]
- 50.Sauvageau S, Thorin E, Caron A, Dupuis J. Evaluation of endothelin-1-induced pulmonary vasoconstriction following myocardial infarction. Exp Biol Med. 2006;231:840–846. [PubMed] [Google Scholar]
- 51.Sauvageau S, Thorin E, Caron A, Dupuis J. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions. J Vasc Res. 2007;44:375–381. doi: 10.1159/000102534. [DOI] [PubMed] [Google Scholar]
- 52.Schuler G, Hambrecht R, Schlierf G, Grunze M, Methfessel S, Hauer K, Kubler W. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol. 1992;19:34–42. doi: 10.1016/0735-1097(92)90048-r. [DOI] [PubMed] [Google Scholar]
- 53.Traverse JH, Kinn JW, Klassen C, Duncker DJ, Bache RJ. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region. J Am Coll Cardiol. 1998;31:67–74. doi: 10.1016/s0735-1097(97)00437-3. [DOI] [PubMed] [Google Scholar]
- 54.Wang QD, Uriuda Y, Pernow J, Hemsén A, Sjöquist PO, Rydén L. Myocardial release of endothelin (ET) and enhanced ET(A) receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs. J Cardiovasc Pharmacol. 1995;26:770–776. doi: 10.1097/00005344-199511000-00014. [DOI] [PubMed] [Google Scholar]
- 55.Watts SW. Endothelin receptors: what’s new and what do we need to know? Am J Physiol. 2010;298:R254–R260. doi: 10.1152/ajpregu.00584.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Wenzel RR, Fleisch M, Shaw S, Noll G, Kaufmann U, Schmitt R, Jones CR, Clozel M, Meier B, Luscher TF. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation. 1998;98:2235–2240. doi: 10.1161/01.cir.98.21.2235. [DOI] [PubMed] [Google Scholar]
- 57.White F, Carroll SM, Magnet A, Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res. 1992;71:1490–1500. doi: 10.1161/01.res.71.6.1490. [DOI] [PubMed] [Google Scholar]
- 58.Zbinden R, Zbinden S, Meier P, Hutter D, Billinger M, Wahl A, Schmid J-P, Windecker S, Meier B, Seiler C. Coronary collateral flow in response to endurance exercise training. Eur J Cardiovasc Prev Rehabil. 2007;14:250–257. doi: 10.1097/HJR.0b013e3280565dee. [DOI] [PubMed] [Google Scholar]
- 59.Zouridakis EG, Schwartzman R, Garcia-Moll X, Cox ID, Fredericks S, Holt DW, Kaski JC. Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J. 2001;22:1578–1584. doi: 10.1053/euhj.2000.2588. [DOI] [PubMed] [Google Scholar]



